Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0994 |
Ketotifen fumarate
HC 20511 fumarate,富马酸酮替芬 |
PDE; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Metabolism; Neuroscience |
Ketotifen fumarate (HC 20511 fumarate) 是组胺 H1 受体和炎症介质释放的环七噻吩阻滞剂。 | |||
T62656 |
GPR81 agonist 1
|
GPR | Endocrinology/Hormones; GPCR/G Protein |
GPR81 agonist 1 是一种具有高效性和选择性的 GPR81 激动剂,对人和小鼠 GPR81 具有很高的亲和力。GPR81 agonist 1 抑制分化的 3T3-L1 脂肪细胞的脂解,改善胰岛素抵抗和糖尿病小鼠模型的胰岛素敏感性和血糖控制,可用于研究糖尿病和肥胖。 | |||
T72772 |
GPR81 agonist 2
|
||
GPR81 agonist 2 是一种有效的GPR81激动剂,对于 hGPR81、hGPR109A 的EC50值分别为 0.023、0.123 µM。 | |||
T62918 |
GPR84 antagonist 3
|
||
GPR84antagonist 3 (compound 42)为一种高效GPR84(G 蛋白偶联受体 84)拮抗剂,具pIC50值为8.28,表现出对GTPγS的抑制作用,并拥有良好的药代动力学特性。 | |||
T72536 |
GPR84 antagonist 2
|
||
GPR84antagonist 2 是一种口服有效的,选择性的 GPR84拮抗剂(IC50=8.95 nM)。GPR84antagonist 2 在钙动员试验中显示出更强的效力,并在 GPR84激活时抑制中性粒细胞和巨噬细胞的趋化性。GPR84antagonist 2 具有研究溃疡性结肠炎的潜力。 | |||
T62261 | GPR84 antagonist 1 | ||
GPR84 antagonist 1 是一种强选择性的、高亲和力的人 GPR84 竞争性拮抗剂。 | |||
T79901 |
GPR88-IN-1
|
||
GPR88-IN-1为GPR88抑制剂,适用于中枢性疾病研究。 | |||
T11462 | GPR84 antagonist 8 | GPR | Endocrinology/Hormones; GPCR/G Protein |
GPR84 antagonist 8 is a selective GPR84 antagonist. | |||
T79902 |
GPR88 agonist 2
|
||
GPR88agonist 2 (compound 53)为高效、能穿透血脑屏障的GPR88激动剂,其在GPR88 cAMP 功能性实验中的EC50为14 nM。 | |||
T36739 | Prednisone 21-aldehyde/22-hydroxy Prednisone | ||
Prednisone 21-aldehyde is a derivative of the synthetic corticosteroid prednisone that has antiviral activity against influenza virus A-PR8 in embryonated chicken eggs. 22-hydroxy Prednisone is an unstable adduct of prednisone. It has been observed following incubation of prednisone with nornicotine. This product is a mixture of prednisone 21-aldehyde and 22-hydroxy prednisone. | |||
T80279 |
Urumin
|
Influenza Virus | Microbiology/Virology |
Urumin 对人类甲型流感病毒显示出抗病毒活性,通过靶向 H1 血凝素的保守茎部位,能有效中和耐药 H1 流感病毒。它在抑制 PR8 流感病毒的生长中的半抑制浓度(IC50)为 3.8 μM,并能保护幼鼠免遭致命流感病毒感染。 | |||
T37466 | CAY10766 | ||
CAY10766 is an antiviral compound.1It inhibits entry of influenza virus-like particles pseudotyped with hemagglutinin A (HA) from H5N1 influenza A virus into A549 cells (EC50= 0.24 μM). CAY10766 (1 μM) reduces H1N1 and H5N1 influenza A viral titers in infected MDCK cells. It also exhibits synergy with oseltamivir carboxylate in MDCK cells infected with the influenza A reporter PR8-NS1-Gluc virus. | |||
T15625 |
JNJ4796
|
Others | Others |
JNJ4796 is an oral active fusion inhibitor of the influenza virus, by inhibiting hemagglutinin (HA)-mediated fusion to neutralizing the influenza A group 1 virus. JNJ4796 mimics the functionality of the broadly neutralizing antibodies (bnAbs). |